June 2021 Br J Cardiol 2021;28:55 doi:10.5837/bjc.2021.024
Mengshi Yuan, Zafraan Zathar, Frantisek Nihaj, Stavros Apostolakis, Fairoz Abdul, Derek Connolly, Chetan Varma, Vinoda Sharma
Abstract
Introduction
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan China and has since spread to over 180 countries.1 It was declared a pandemic by the World Health Organization (WHO) in March 2020.
In addition to the common respiratory clinical presentation, COVID-19 is associated with cardiovascular complications, which may contribute to patients’ demise.2 The most common is myocardial injury, indicated by a serum troponin rise, which has also been found to be a reliable indicator of disease severity.3 Cardiac arrhythmia is another common cardiovascular manifestati
|
Full text
